Merck and Ablynx have entered into a partnership to develop Nanobody candidates against a voltage gated ion channel and includes an option to elect a second target. As a part of the agreement, Ablynx will be responsible for the discovery ...
Tags: Nanobody Candidates, Nanobody technology, Ablynx Partner